CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's EPS Net Growth by Quarter and Year

Atara Biotherapeutics,'s EPS Net results by quarter and year




ATRA EPS Net (in $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - -1.15 -0.63 -
III Quarter September -1.29 -1.02 -0.88 -0.43
II Quarter June -1.15 -0.94 -0.66 -0.62
I Quarter March -1.05 -0.88 -0.58 -0.42
FY   -3.49 -3.99 -2.75 -1.47



ATRA EPS Net third quarter 2018 Y/Y Growth Comment
Atara Biotherapeutics, Inc. in the third quarter recorded EPS net loss of $ -1.29 .

According to the results reported in the third quarter, Atara Biotherapeutics, Inc. achieved the best EPS Net growth in Biotechnology & Drugs industry. While Atara Biotherapeutics, Inc.' s EPS Net no change of % ranks overall at the positon no. in the third quarter.




ATRA EPS Net ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics,'s third quarter 2018 EPS Net $ 0.00 ATRA's Income Statement
Atara Biotherapeutics,'s third quarter 2017 EPS Net $ 0.00 Quarterly ATRA's Income Statement
New: More ATRA's historic EPS Net Growth >>


ATRA EPS Net (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Atara Biotherapeutics,'s Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's III. Quarter Q/Q EPS Net Comment
Current accomplishment of -1.29 by Atara Biotherapeutics, Inc. come out even less good compare to the -1.15 in the previous quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential EPS Net growth. While Atara Biotherapeutics,'s EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's III. Quarter Q/Q EPS Net Comment
Recent accomplishment of -1.29 by Atara Biotherapeutics, Inc. look even worse considering the EPS net loss -1.15 in the previous quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential EPS Net growth. While Atara Biotherapeutics,'s EPS Net growth quarter on quarter, overall rank is .


Atara Biotherapeutics,'s 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
Cumulative EPS Net 12 Months Ending $ -4.64 $ -4.37 $ -4.16 $ -3.99 $ -3.47
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months EPS net loss of $ -5 in the Sep 30 2018 period.
The results are getting worse as the cumulative EPS net loss is becoming larger from $ -4.37 in the twelve months ending a quarter before and $ -1.15 from the TTM period ending Sep 30 2017.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months EPS net loss of $ -5 in the Sep 30 2018 period.
The situation is worsening as the cumulative EPS net loss is inflating from $ -4.37 in TTM ending quarter Jun 30 2018 and $ -1.15 for the twelve months ending in the quarter a year ago.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Biotechnology & Drugs Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
ATRA's EPS Net Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for ATRA's Competitors
EPS Net Growth for Atara Biotherapeutics,'s Suppliers
EPS Net Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Sep 30 2018 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Sep 30 2018
Orasure Technologies Inc  44.44 %$ 44.444 
Chemed Corp  43.66 %$ 43.662 
Radnet, Inc.  42.86 %$ 42.857 
Stryker Corp  35.96 %$ 35.965 
Edwards Lifesciences Corp  34.18 %$ 34.177 
Quest Diagnostics Inc  33.04 %$ 33.043 
Idexx Laboratories Inc  32.91 %$ 32.911 
Encompass Health Corp  32.84 %$ 32.836 
Hill-rom Holdings, Inc.  29.50 %$ 29.501 
Pdl Biopharma, Inc.  28.57 %$ 28.571 
Tactile Systems Technology Inc  28.57 %$ 28.571 
Corcept Therapeutics Inc  27.27 %$ 27.273 
Universal Health Services Inc  25.17 %$ 25.170 
Merrimack Pharmaceuticals Inc  25.00 %$ 25.000 
Celgene Corp  23.97 %$ 23.967 
Mettler Toledo International Inc  23.56 %$ 23.559 
Biogen Inc.  23.49 %$ 23.489 
Align Technology Inc  22.77 %$ 22.772 
Bruker Corp  21.74 %$ 21.739 
Resmed Inc  21.67 %$ 21.667 
Steris Plc  21.33 %$ 21.333 
Petmed Express Inc  20.93 %$ 20.930 
Atrion Corp  15.62 %$ 15.618 
Anika Therapeutics, Inc.  15.22 %$ 15.217 
Tabula Rasa Healthcare, Inc.  14.63 %$ 14.634 
Zynex Inc  14.29 %$ 14.286 
Icon Plc  14.07 %$ 14.074 


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AUO's Profile

Stock Price

AUO's Financials

Business Description

Fundamentals

Charts & Quotes

AUO's News

Suppliers

AUO's Competitors

Customers & Markets

Economic Indicators

AUO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071